Experiment 1324086
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | MORITA,M: YAMADA,K: DATE,H: KAZUE HAYAKAWA,K: SAKURAI,H: YAMADA,H:. (2018). EFFICACY OF CHONDROITIN SULFATE FOR PAINFUL KNEE OSTEOARTHRITIS: A ONE-YEAR, RANDOMIZED, DOUBLE-BLIND, MULTICENTER CLINICAL STUDY IN JAPAN. 41(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | STUDY OF THE EFFECT OF CHONDROITIN SULFATE THERAPY ON KNEE OSTEOARTHRITIS IN A ONE-YEAR, RANDOMIZED, DOUBLE- BLIND, DOSE-COMPARISON STUDY. PATIENTS WITH PAINFUL OSTEOARTHRITIS OF THE KNEE WERE TREATED WITH ORAL CHONDROITIN SULFATE AT A DOSE OF EITHER 260 MG/DAY OR 1,560 MG/DAY (HIGH-DOSE GROUP). SYMPTOMS WERE EVALUATED BY THE LEQUESNE’S INDEX AND VISUAL ANALOG SCALE FOR PAIN IN 73 PATIENTS. IN THE SUBGROUP WITH SEVERE SYMPTOMS (LEQUESNE’S INDEX ≥8), THE CHONDROITIN SULFATE DOSE OF 1,560 MG/DAY IMPROVED PAIN FASTER AFTER 6 AND 9 MONTHS’ THERAPY. THE STUDY CONCLUDED THAT CHONDROITIN SULFATE IS USEFUL FOR PAIN CONTROL IN KNEE OSTEOARTHRITIS. |
| Dose amount | 1.56 GM |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |